Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.7K
T Cell Types and Functions01:24

T Cell Types and Functions

946
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
946
Inflammatory Response01:28

Inflammatory Response

1.8K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
1.8K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

381
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
381

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Markers Predicting Cure With Combinatorial Treatment in a Mouse Model of Latent Autoimmune Diabetes in Adults.

MedComm·2026
Same author

Par2-mediated responses in inflammation and regeneration: choosing between repair and damage.

Inflammation and regeneration·2024
Same author

Resolving the conflicts around Par2 opposing roles in regeneration by comparing immune-mediated and toxic-induced injuries.

Inflammation and regeneration·2022
Same author

Gestational diabetes induces behavioral and brain gene transcription dysregulation in adult offspring.

Translational psychiatry·2020

Related Experiment Video

Updated: Jun 3, 2025

Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control
07:13

Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control

Published on: May 24, 2024

408

A New Strategy in Modulating the Protease-Activated Receptor 2 (Par2) in Autoimmune Diseases.

Lynn Khoon1, Ron Piran1

  • 1The Azrieli Faculty of Medicine, Bar-Ilan University, Safed 1311502, Israel.

International Journal of Molecular Sciences
|January 11, 2025
PubMed
Summary

Protease-activated receptor 2 (Par2) plays a dual role in autoimmune diseases, promoting inflammation and tissue repair. Understanding its context-specific functions is key to developing targeted therapies for conditions like rheumatoid arthritis and type 1 diabetes.

Keywords:
G protein-coupled receptors (GPCR)autoimmunityinflammationprotease-activated receptorsregenerationregenerative medicine

More Related Videos

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity
10:10

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity

Published on: November 8, 2016

8.7K
Author Spotlight: Insights and Innovations in Gene Expression Manipulation Techniques for Choroid Plexus Research
04:43

Author Spotlight: Insights and Innovations in Gene Expression Manipulation Techniques for Choroid Plexus Research

Published on: June 16, 2023

867

Related Experiment Videos

Last Updated: Jun 3, 2025

Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control
07:13

Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control

Published on: May 24, 2024

408
Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity
10:10

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity

Published on: November 8, 2016

8.7K
Author Spotlight: Insights and Innovations in Gene Expression Manipulation Techniques for Choroid Plexus Research
04:43

Author Spotlight: Insights and Innovations in Gene Expression Manipulation Techniques for Choroid Plexus Research

Published on: June 16, 2023

867

Area of Science:

  • Immunology
  • Pathophysiology
  • Pharmacology

Background:

  • Autoimmune diseases involve immune-mediated damage and chronic inflammation.
  • Protease-activated receptor 2 (Par2) has a complex, dual role in these conditions.
  • Par2's function varies, complicating its therapeutic use.

Purpose of the Study:

  • To review the dual roles of Par2 in autoimmune diseases.
  • To analyze how context and location of Par2 activation influence its effects.
  • To explore context-specific therapeutic strategies targeting Par2.

Main Methods:

  • Literature review of Par2's function in autoimmune conditions.
  • Analysis of findings in rheumatoid arthritis, type 1 diabetes, and inflammatory bowel disease.
  • Examination of recent laboratory studies distinguishing Par2's inflammatory and reparative roles.

Main Results:

  • Par2 promotes inflammation via immune cell activation.
  • Par2 also facilitates tissue healing in damaged organs.
  • Context-specific activation determines whether Par2 promotes inflammation or repair.

Conclusions:

  • Par2's dual role presents therapeutic challenges and opportunities.
  • Selective Par2 modulators could mitigate inflammation while enhancing repair.
  • Further research into Par2 signaling pathways is needed for precise therapeutic strategies.